Vol 28, No 3 (2021)
Original Article
Published online: 2020-02-25

open access

Page views 1270
Article views/downloads 1309
Get Citation

Connect on Social Media

Connect on Social Media

The impact of dissection and re-entry versus wire escalation techniques on long-term clinical outcomes in patients with chronic total occlusion lesions following percutaneous coronary intervention: An updated meta-analysis

Yejing Zhao1, Hongyu Peng1, Xiaonan Li1, Jinghua Liu1
Pubmed: 32104900
Cardiol J 2021;28(3):369-383.

Abstract

Background: The meta-analysis was performed to evaluate the effect of dissection and re-entry (DR) vs. wire escalation (WE) techniques on long-term clinical outcomes in patients with chronic total occlusion (CTO) lesions undergoing percutaneous coronary intervention.

Methods: Studies were searched in electronic databases from inception to September, 2019. Results were pooled using random effects model and fixed effects model and are presented as risk ratios (RR) with 95% confidence intervals (CI).

Results: Pooled analyses revealed that patients with DR techniques had overall higher complexity CTO lesions than patients with WE techniques and required a greater number of stents and a greater mean stent length. The “extensive” DR techniques may have a higher incidence of target vessel revascularization (TVR) (RR = 2.30, 95% CI: 1.77–2.98), in-stent restenosis (RR = 1.71, 95% CI: 1.30–2.23), in-stent reocclusion (RR = 1.86, 95% CI: 1.03–3.3) and death/myocardial infarction/TVR (RR = 2.10, 95% CI: 1.71–2.58), when compared with WE techniques, during the long-term follow-up. However, “limited” DR techniques result in more promising outcomes, and are comparable to conventional WE techniques.

Conclusions: Dissection and re-entry techniques were associated with increased risk of long-term negative clinical events, especially “extensive” DR techniques. However, “limited” DR techniques resulted in good long-term outcomes, comparable to WE techniques.

Article available in PDF format

View PDF Download PDF file

References

  1. Tajti P, Karmpaliotis D, Alaswad K, et al. The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry. JACC Cardiovasc Interv. 2018; 11(14): 1325–1335.
  2. Hall AB, Brilakis ES. Hybrid 2.0: Subintimal plaque modification for facilitation of future success in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2019; 93(2): 199–201.
  3. Azzalini L, Carlino M, Brilakis ES, et al. Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of "vessel architecture". Catheter Cardiovasc Interv. 2018; 91(4): 725–734.
  4. Owen M, Vishal PG, Tesfaldet MT, et al. Long-term outcomes with use of the CrossBoss and stingray coronary CTO crossing and re-entry devices. J Invasive Cardiol. 2013; 25(11): 579–585.
  5. Karatasakis A, Danek BA, Karacsonyi J, et al. Mid-term outcomes of chronic total occlusion percutaneous coronary intervention with subadventitial vs. intraplaque crossing: A systematic review and meta-analysis. Int J Cardiol. 2018; 253: 29–34.
  6. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9): 603–605.
  7. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17(1): 1–12.
  8. Ades AE, Lu G, Higgins JPT. The interpretation of random-effects meta-analysis in decision models. Med Decis Making. 2005; 25(6): 646–654.
  9. DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015; 45(Pt A): 139–145.
  10. Borenstein M, Higgins JPT. Meta-analysis and subgroups. Prev Sci. 2013; 14(2): 134–143.
  11. Azzalini L, Dautov R, Brilakis ES, et al. Impact of crossing strategy on midterm outcomes following percutaneous revascularisation of coronary chronic total occlusions. EuroIntervention. 2017; 13(8): 978–985.
  12. Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006; 25(20): 3443–3457.
  13. Seagroatt V, Stratton I. Bias in meta-analysis detected by a simple, graphical test. Test had 10% false positive rate. BMJ. 1998; 316(7129): 470; author reply 470–470; author reply 471.
  14. Finn MT, Doshi D, Cleman J, et al. Intravascular ultrasound analysis of intraplaque versus subintimal tracking in percutaneous intervention for coronary chronic total occlusions: One year outcomes. Catheter Cardiovasc Interv. 2019; 93(6): 1048–1056.
  15. Maeremans J, Avran A, Walsh S, et al. One-Year Clinical Outcomes of the Hybrid CTO Revascularization Strategy After Hospital Discharge: A Subanalysis of the Multicenter RECHARGE Registry. J Invasive Cardiol. 2018; 30(2): 62–70.
  16. Sabbah M, Tada T, Kadota K, et al. Clinical and angiographic outcomes of true vs. false lumen stenting of coronary chronic total occlusions: Insights from intravascular ultrasound. Catheter Cardiovasc Interv. 2019; 93(3): E120–E129.
  17. Wilson WM, Walsh SJ, Bagnall A, et al. One-year outcomes after successful chronic total occlusion percutaneous coronary intervention: The impact of dissection re-entry techniques. Catheter Cardiovasc Interv. 2017; 90(5): 703–712.
  18. Hasegawa K, Tsuchikane E, Okamura A, et al. Incidence and impact on midterm outcome of intimal versus subintimal tracking with both antegrade and retrograde approaches in patients with successful recanalisation of chronic total occlusions: J-PROCTOR 2 study. EuroIntervention. 2017; 12(15): e1868–e1873.
  19. Muramatsu T, Tsuchikane E, Oikawa Y, et al. Incidence and impact on midterm outcome of controlled subintimal tracking in patients with successful recanalisation of chronic total occlusions: J-PROCTOR registry. EuroIntervention. 2014; 10(6): 681–688.
  20. Rinfret S, Ribeiro HB, Nguyen CM, et al. Dissection and re-entry techniques and longer-term outcomes following successful percutaneous coronary intervention of chronic total occlusion. Am J Cardiol. 2014; 114(9): 1354–1360.
  21. Amsavelu S, Christakopoulos GE, Karatasakis A, et al. Impact of crossing strategy on intermediate-term outcomes after chronic total occlusion percutaneous coronary intervention. Can J Cardiol. 2016; 32(10): 1239.e1–1239.e7.
  22. Godino C, Latib A, Economou FI, et al. Coronary chronic total occlusions: mid-term comparison of clinical outcome following the use of the guided-STAR technique and conventional anterograde approaches. Catheter Cardiovasc Interv. 2012; 79(1): 20–27.
  23. Valenti R, Vergara R, Migliorini A, et al. Predictors of Reocclusion After Successful Drug-Eluting Stent–Supported Percutaneous Coronary Intervention of Chronic Total Occlusion. J Am Coll Cardiol. 2013; 61(5): 545–550.
  24. Tanaka H, Hosogi S, Fuku Y, et al. TCT-208: Angiographic and Clinical Outcomes of Retrograde Recanalization for Chronic Total Occlusions. J Am Coll Cardiol. 2010; 56(13): B48.
  25. Brilakis ES, Grantham JA, Rinfret S, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv. 2012; 5(4): 367–379.
  26. Erlich I, Strauss BH, Butany J. Stent thrombosis following the STAR technique in a complex RCA chronic total occlusion. Catheter Cardiovasc Interv. 2006; 68(5): 708–712.
  27. Valenti R, Vergara R, Migliorini A, et al. Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion. J Am Coll Cardiol. 2013; 61(5): 545–550.
  28. Tsujita K, Maehara A, Mintz GS, et al. Cross-sectional and longitudinal positive remodeling after subintimal drug-eluting stent implantation: multiple late coronary aneurysms, stent fractures, and a newly formed stent gap between previously overlapped stents. JACC Cardiovasc Interv. 2009; 2(2): 156–158.
  29. Hiromasa T, Kuramitsu S, Shinozaki T, et al. Impact of total stent length after cobalt chromium everolimus-eluting stent implantation on 3-year clinical outcomes. Catheter Cardiovasc Interv. 2017; 89(2): 207–216.
  30. Colombo A, Mikhail GW, Michev I, et al. Treating chronic total occlusions using subintimal tracking and reentry: the STAR technique. Catheter Cardiovasc Interv. 2005; 64(4): 407–11; discussion 412.
  31. Galassi AR, Tomasello SD, Costanzo L, et al. Mini-STAR as bail-out strategy for percutaneous coronary intervention of chronic total occlusion. Catheter Cardiovasc Interv. 2012; 79(1): 30–40.
  32. Michael TT, Mogabgab O, Alomar M, et al. Long-term outcomes of successful chronic total occlusion percutaneous coronary interventions using the antegrade and retrograde approach. J Interv Cardiol. 2014; 27(5): 465–471.
  33. Kimura M, Katoh O, Tsuchikane E, et al. The efficacy of a bilateral approach for treating lesions with chronic total occlusions the CART (controlled antegrade and retrograde subintimal tracking) registry. JACC Cardiovasc Interv. 2009; 2(11): 1135–1141.
  34. Whitlow PL, Burke MN, Lombardi WL, et al. Use of a novel crossing and re-entry system in coronary chronic total occlusions that have failed standard crossing techniques: results of the FAST-CTOs (Facilitated Antegrade Steering Technique in Chronic Total Occlusions) trial. JACC Cardiovasc Interv. 2012; 5(4): 393–401.
  35. Tsuchikane E, Katoh O, Kimura M, et al. The first clinical experience with a novel catheter for collateral channel tracking in retrograde approach for chronic coronary total occlusions. JACC Cardiovasc Interv. 2010; 3(2): 165–171.
  36. Rathore S, Terashima M, Suzuki T. Value of intravascular ultrasound in the management of coronary chronic total occlusions. Catheter Cardiovasc Interv. 2009; 74(6): 873–878.
  37. Muhammad KI, Lombardi WL, Christofferson R, et al. Subintimal guidewire tracking during successful percutaneous therapy for chronic coronary total occlusions: insights from an intravascular ultrasound analysis. Catheter Cardiovasc Interv. 2012; 79(1): 43–48.
  38. Song L, Maehara A, Finn MT, et al. Intravascular ultrasound analysis of intraplaque versus subintimal tracking in percutaneous intervention for coronary chronic total occlusions and association with procedural outcomes. JACC Cardiovasc Interv. 2017; 10(10): 1011–1021.